Naz Rahman

Q: What is Naz Rahman's success rate?

Naz Rahman currently has a success rate of 72.63017602751086.

Q: What is the average return of Naz Rahman's calls?

Their stock ratings have generated an average return of 43.48502676768587.

Maxim Group | Healthcare

Naz Rahman is an analyst from Maxim Group specializing in the Healthcare sector. Ranked #1257 out of 4580 analysts, they have issued 9 stock ratings with a success rate of 72.63% and an average return of 43.49%.

With 9 ratings to date, Naz Rahman is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 72.63% and an average return of 43.49%, highlighting promising potential as their track record develops further.

#1257

Out of 4580

Total Ratings

+72.63%

Success Rate

+43.49%

Average Return

Recent Ratings Analysis

VRTX

Buy

Mar 18, 2026

Target

$575.00

Current

$451.59

Performance

0.00%

Naz Rahman rated VRTX as Buy on Mar 18, 2026, setting a price target of 575. Shares have remained stable near 451.59, leaving the 575 target still in play.

NXGL

Buy

Mar 12, 2026

Target

$6.00

Current

$0.80

Performance

-15.80%

On Mar 12, 2026, NXGL was given a Buy rating by Naz Rahman, with a target price of 6. Despite the Buy call, shares fell from 0.8045 to 0.8045, challenging the optimistic stance.

SCNX

Buy

Feb 24, 2026

Target

$1.50

Current

$0.48

Performance

26.17%

SCNX received a Buy rating from Naz Rahman on Feb 24, 2026, aiming for 1.5. Momentum has favored the Buy call, with shares climbing from 0.485 to 0.485, rewarding those who trusted the recommendation.

KZIA

Buy

Oct 02, 2025

Target

$20.00

Current

$7.51

Performance

19.02%

On Oct 02, 2025, Naz Rahman published a Buy outlook on KZIA, with a target of 20. Shares gained 19.02%, underscoring the accuracy of the bullish outlook toward 20.

AYTU

Buy

Sep 25, 2025

Target

$7.00

Current

$2.60

Performance

39.78%

Naz Rahman on Sep 25, 2025 assigned AYTU a Buy rating, with a price target of 7. The Buy call aligned well with market performance, producing a gain of 39.78%.

SCPH

Hold

Aug 25, 2025

Target

—

Current

$5.67

Performance

2.72%

On Aug 25, 2025, Naz Rahman reaffirmed SCPH with a Hold rating, targeting null. The neutral call matched muted market action of 2.72%.

GLMD

Hold

Apr 04, 2025

Target

—

Current

$0.61

Performance

-54.35%

GLMD was rated Hold by Naz Rahman on Apr 04, 2025, with a price objective of null. Investors who stayed cautious avoided some of the 54.35% decline.

NVCT

Buy

Apr 02, 2025

Target

$17.00

Current

$8.22

Performance

-13.11%

On Apr 02, 2025, Naz Rahman initiated coverage on NVCT with a Buy rating and target of 17. The Buy call has yet to be validated as shares remain 8.78 away from the target.

SLXN

Buy

Mar 20, 2025

Target

$5.00

Current

$1.53

Performance

-90.81%

Naz Rahman issued a Buy recommendation for SLXN on Mar 20, 2025, price target set at 5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

VKTX

Buy

Feb 07, 2025

Target

$70.00

Current

$33.55

Performance

3.04%

On Feb 07, 2025, VKTX was evaluated by Naz Rahman, who gave a Buy rating and target of 70. So far, the Buy call awaits clearer momentum, with shares flat at 33.55.

NRSN

Hold

Dec 16, 2024

Target

—

Current

$0.77

Performance

-12.36%

Naz Rahman rated NRSN as Hold on Dec 16, 2024, setting a price target of null. The cautious Hold call aligned with subsequent weakness, as shares slipped 12.36%.

CING

Buy

Nov 20, 2024

Target

—

Current

$8.04

Performance

79.46%

On Nov 20, 2024, CING was given a Buy rating by Naz Rahman, with a target price of null. The stock rallied 79.46% after the rating, narrowing the gap to the target of null and validating the bullish stance.

VRPX

Hold

Oct 09, 2024

Target

—

Current

$0.01

Performance

-99.91%

VRPX received a Hold rating from Naz Rahman on Oct 09, 2024, aiming for null. The Hold stance proved prudent, with the market softening by 99.91%.

ASRT

Buy

Jul 26, 2024

Target

$3.00

Current

$13.68

Performance

-95.97%

On Jul 26, 2024, Naz Rahman published a Buy outlook on ASRT, with a target of 3. Market action contradicted the Buy thesis, as shares slipped to 13.68.

PRFX

Buy

Jun 26, 2024

Target

$2.00

Current

$2.33

Performance

-95.89%

Naz Rahman on Jun 26, 2024 assigned PRFX a Buy rating, with a price target of 2. The call has struggled to gain traction, with shares losing 95.89%.

ALIM

Hold

Jun 25, 2024

Target

—

Current

$5.54

Performance

0.36%

On Jun 25, 2024, Naz Rahman reaffirmed ALIM with a Hold rating, targeting null. The neutral call matched muted market action of 0.36%.

PALI

Buy

May 01, 2024

Target

$22.50

Current

$1.97

Performance

-72.18%

PALI was rated Buy by Naz Rahman on May 01, 2024, with a price objective of 22.5. This case shows how bullish projections can fail, with the stock now below 1.97.

Frequency Asked Questions

Who is Naz Rahman?

Naz Rahman is an analyst from Maxim Group specializing in the Healthcare sector.

What is Naz Rahman's success rate?

Naz Rahman currently has a success rate of +72.63%.

How many ratings has Naz Rahman issued?

Naz Rahman has issued 9 stock ratings so far.

What is the average return of Naz Rahman's calls?

Their stock ratings have generated an average return of +43.49%.

What is Naz Rahman's ranking?

Naz Rahman is ranked #1257 out of 4580 analysts.

What types of ratings does Naz Rahman give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Naz Rahman?

You can follow Naz Rahman by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Naz Rahman?

Their latest rating was a Buy on VRTX issued on 2026-03-18.